No abstract available
MeSH terms
-
Angiotensin II Type 1 Receptor Blockers / administration & dosage
-
Angiotensin II Type 1 Receptor Blockers / economics
-
Angiotensin-Converting Enzyme Inhibitors / administration & dosage
-
Angiotensin-Converting Enzyme Inhibitors / economics
-
Antihypertensive Agents / administration & dosage
-
Antihypertensive Agents / adverse effects
-
Antihypertensive Agents / economics*
-
Calcium Channel Blockers / administration & dosage
-
Calcium Channel Blockers / economics
-
Cost Savings
-
Cost-Benefit Analysis
-
Diuretics / administration & dosage
-
Diuretics / economics
-
Drug Costs
-
Humans
-
Hypertension / drug therapy
-
Hypertension / economics*
-
Outcome Assessment, Health Care
-
Practice Patterns, Physicians' / economics
-
Sweden
Substances
-
Angiotensin II Type 1 Receptor Blockers
-
Angiotensin-Converting Enzyme Inhibitors
-
Antihypertensive Agents
-
Calcium Channel Blockers
-
Diuretics